Exact Mass: 546.1591
Exact Mass Matches: 546.1591
Found 142 metabolites which its exact mass value is equals to given mass value 546.1591
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
hypocrellin a
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].
Hypocrellin
Hypocrellin is a natural product found in Parastagonospora nodorum with data available. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].
8)-epicatechin
6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]fisetinidol
hypocrellin a
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].
8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]fisetinidol
4-(2,4-Dihydroxyphenyl)-2-(3,4-dihydroxyphenyl)-3,3,4,4-tetrahydro(2,6)-bis-2H-1-benzopyran3,3,7,8-tetraol
8,9-Dihydro-10-(2,4-dihydroxyphenyl)-9-hydroxy-8-(4-hydroxyphenyl)-10H-pyrano[2,3-h]-ent-fisetinidol
6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]-ent-epifisetnidol
8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]-ent-epifisetinidol
phomalevone A
A biaryl that is 5,5,10a,10a-tetrahydro-9H,9H-2,2-bixanthene-9,9-dione substituted by hydroxy groups at positions 1, 1, 5, 5, 8 and 8 and methyl groups at positions 3, 3, 10a and 10a. Isolated from the cultures of a Hawaiian isolate of the fungus Phoma species, it exhibits antibacterial activity.
Phomalevone B
A member of the class of biphenyls that is 6,6-dimethylbiphenyl-2,2,4,4-tetrol which has been substituted by 3,6-dihydroxy-2-methylbenzoyl groups at positions 3 and 3. Isolated from the cultures of a Hawaiian isolate of the fungus Phoma species, it exhibits antibacterial and antifungal activities.
(E)-3,3?-(2-methylpropane-1,1-diyl)-bis(6-((E)-3,4-dihydroxystyryl)-4-hydroxy-2H-pyran-2-one)|phaeolschidin A
7-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl-6,8-dimethoxy-7-hydroxycoumarin|nitensoside B
6-(3,7-dihydro xychroman-2-yl)-4-(2,4-dihydroxyphenyl)-3,3,4,8-tetrahydro xyflavan
Bepotastine Besilate
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Bepotastine besilate is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine besilate has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].
Cys Met Met Tyr
Cys Met Tyr Met
Cys Tyr Met Met
Met Cys Met Tyr
Met Cys Tyr Met
Met Met Cys Tyr
Met Met Tyr Cys
Met Tyr Cys Met
Met Tyr Met Cys
Tyr Cys Met Met
Tyr Met Cys Met
Tyr Met Met Cys
CHAETOCHROMIN A
A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2, 3 and 3 (the 2R,2S,3R,3S stereoisomer). It has been isolated from Chaetomium gracile.
Chaetochromin B
A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2, 3 and 3 (the 2R,2S,3R,3R stereoisomer). It has been isolated from Chaetomium gracile.
Afzelechin-(4alpha->8)-afzelechin
A biflavonoid consisting of two molecules of afzelechin joined by a (4alpha->8) linkage.
(2R,2S,3R,3S)-5,5,6,6,8,8-hexahydroxy-2,2,3,3-tetramethyl-2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione
4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[(2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl (2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoate
(2r,3s)-8-[(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
(2r,3r)-8-[(2s,4r)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[3-(3-methyloxiran-2-yl)prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl 3-(3-methyloxiran-2-yl)prop-2-enoate
(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol
4-[(5r,5''r)-5,5''-bis[(1s)-1-hydroxyethyl]-2'-(4-hydroxyphenyl)-5h,5''h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-furan]-1',3'(7'),8'-trien-8'-yl]phenol
(2s,3r)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one
(2r,13s)-16-(2,6-dihydroxy-4-methylbenzoyl)-1,8,10,15,18-pentahydroxy-2,6,17-trimethyl-3-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-4,6,8,10,14,16,18-heptaen-12-one
1,1',4',5,5',8'-hexahydroxy-3,7-dimethyl-1',2',3',4',5',6',7',8'-octahydro-[2,2'-bianthracene]-9,9',10,10'-tetrone
(5r,5''s,6''r)-5-[(1s)-1-hydroxyethyl]-2',8'-bis(4-hydroxyphenyl)-6''-methyl-5'',6''-dihydro-5h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-pyran]-1',3'(7'),8'-trien-5''-ol
(13s,14r)-14-acetyl-7,13,19-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3,5,7,10,15,18(23),19,21-nonaene-9,17-dione
(2s,3s,4s)-2-(4-hydroxyphenyl)-4-[(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
(12s,13r)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione
(2r,3r)-2-(4-hydroxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
3',4',7-trihydroxyflavan(4→8)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4r)-form
{"Ingredient_id": "HBIN007318","Ingredient_name": "3',4',7-trihydroxyflavan(4\u21928)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4r)-form","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "NA","Ingredient_weight": "546.52","OB_score": "NA","CAS_id": "162753-74-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8302","PubChem_id": "NA","DrugBank_id": "NA"}
3',4',7-trihydroxyflavan(4→8)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4s)-form
{"Ingredient_id": "HBIN007319","Ingredient_name": "3',4',7-trihydroxyflavan(4\u21928)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4s)-form","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "NA","Ingredient_weight": "546.52","OB_score": "NA","CAS_id": "162869-46-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8301","PubChem_id": "NA","DrugBank_id": "NA"}
afzelechin-(4α→8)-afzelechin
{"Ingredient_id": "HBIN014789","Ingredient_name": "afzelechin-(4\u03b1\u21928)-afzelechin","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC=C(C=C5)O)O)O)O)C6=CC=C(C=C6)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "678","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}